宠物类固醇市场规模、份额和成长分析：按产品类型、配方类型、动物种类、最终用户和地区划分－2026-2033年产业预测

2024年全球宠物类固醇市场价值为11亿美元，预计将从2025年的11.8亿美元成长到2033年的20.1亿美元。预测期（2026-2033年）的复合年增长率预计为6.9%。

全球兽用类固醇市场的主要驱动力是伴侣动物慢性发炎和免疫介导疾病的日益增多，以及宠物饲主对兽医护理投入的意愿不断提高。这个领域涵盖用于抑制发炎、治疗过敏和自体免疫疾病的皮质类固醇，能够快速缓解症状，提高宠物的生活质量，同时也带来了稳定的处方需求。市场正从偶尔的仿单标示外用药发展到标准化製剂、学名药的日益普及以及线上零售通路的扩张。关键的成长要素包括药物取得途径的改善、治疗模式的转变以及宠物保险的日益普及。人工智慧技术透过预测分析和即时数据分析增强了安全性监测，从而提高了治疗效率并增强了市场信心。

推动全球宠物类固醇市场发展的因素

宠物饲主对慢性发炎和内分泌疾病的认识不断提高，促使宠物就诊次数增加，药物治疗的接受度也随之提高，从而带动了对类固醇疗法的需求。针对宠物饲主的宣传活动、活跃的线上社群以及兽医资讯传播的加强，都使人们对相关症状和类固醇疗法的益处有了更深入的了解。诊断方法的进步和沟通方式的改进，促使宠物饲主更加严格地遵医嘱进行类固醇治疗，最终提高了类固醇产品在伴侣动物医疗保健领域的市场渗透率和接受度。

全球宠物类固醇市场的限制因素

由于法规结构严格以及人们对动物使用类固醇的安全性日益关注，全球宠物类固醇市场面临严峻挑战。这些因素增加了产品核可和上市后监测的复杂性和成本，可能阻碍新配方的及时上市。此外，对潜在副作用、长期使用风险以及防止滥用的担忧，使得更严格的标籤和监测成为必要。因此，兽医和宠物饲主在开立和使用类固醇时往往更加谨慎。这种谨慎的态度限制了产品的日常使用量，缩小了市场产品种类，并阻碍了製造商进入该领域，即使存在明显的临床需求。

全球宠物类固醇市场趋势

随着宠物饲主越来越将宠物视为家庭成员，全球宠物类固醇市场正经历一场重大变革时期。这推动了对个人化治疗方法日益增长的需求，宠物主人也越来越希望获得关于类固醇疗法益处和使用方法的透明资讯。人们越来越倾向于选择能够改善宠物生活品质、促进宠物健康并减轻其压力的配方。为了满足这一需求，製造商正透过开发便捷的给药方案、全面的教育资源和药物支持计划，不断扩大其在高端市场的份额，从而满足宠物饲主的期望并增强品牌忠诚度。

目录

介绍

• 调查目的
• 市场定义和范围

调查方法

• 研究过程
• 二级资料和一级资料的方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 市场主要亮点
• 细分市场概览
• 竞争环境概述

市场动态及展望

• 总体经济指标
• 促进者和机会
• 抑制因素和挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

市场考察

• 关键成功因素
• 影响市场的因素
• 主要投资机会
• 生态系测绘
• 2025年市场吸引力指数
• PESTEL 分析
• 监理情势

全球宠物类固醇市场规模：依产品类型及复合年增长率划分（2026-2033 年）

• 合成代谢类固醇
  • 注射用合成代谢药物
  • 口服合成代谢药物
• 皮质类固醇
  • 局部皮质类固醇
  • 注射用皮质类固醇

全球宠物类固醇市场规模：依剂型及复合年增长率划分（2026-2033 年）

• 药片
• 液体
• 粉末

全球宠物类固醇市场规模：按动物类型和复合年增长率划分（2026-2033 年）

• 狗
• 猫
• 其他的

全球宠物类固醇市场规模：按最终用户和复合年增长率划分（2026-2033 年）

• 动物医院
• 宠物饲主
• 宠物药房

全球宠物类固醇市场规模及复合年增长率（2026-2033）

• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场公司采取的策略
• 近期市场趋势
• 企业市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 按细分市场进行企业市占率分析
  • 2023-2025年营收年比比较

主要企业简介

• Zoetis
• Merck Animal Health
• Elanco
• VytoMed
• PetMed Express
• Bayer Animal Health
• Ceva Animal Health
• VetEmergencies
• PetSage
• Arecibo Animal Hospital
• PetTech Pharmaceuticals
• VetBiologics
• Animal Health International
• Dechra Veterinary Products
• Vetoquinol
• ScanVet
• Neogen Corporation
• Royal Canin
• PetIQ
• Nutramax Laboratories

结论与建议

Global Steroids For Pets Market size was valued at USD 1.1 Billion in 2024 and is poised to grow from USD 1.18 Billion in 2025 to USD 2.01 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global steroids for pets market is primarily driven by the increasing prevalence of chronic inflammatory and immune-mediated conditions in companion animals, coupled with pet owners' growing willingness to invest in veterinary care. This sector includes corticosteroids used for inflammation control, allergies, and autoimmune disorders, providing rapid relief and improving pets' quality of life while fostering consistent prescription demand. The market has evolved from occasional off-label usage to standardized formulations, enhanced generic availability, and expanding online retail avenues. Key growth factors include better access to these medications, shifts in treatment paradigms, and the rise of pet insurance. AI technologies are enhancing safety monitoring through predictive analytics and real-time data analysis, thus improving treatment efficiency and increasing market confidence.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Steroids For Pets market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Steroids For Pets Market Segments Analysis

Global steroids for pets market is segmented by product type, formulation type, animal type, end user and region. Based on product type, the market is segmented into Anabolic Steroids and Corticosteroids. Based on formulation type, the market is segmented into Tablets, Liquid Solutions and Powdered Form. Based on animal type, the market is segmented into Dogs, Cats and Others. Based on end user, the market is segmented into Veterinary Clinics, Pet Owners and Pet Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Steroids For Pets Market

The rising awareness among pet owners regarding chronic inflammatory and endocrine disorders has resulted in an increase in veterinary visits and a growing acceptance of pharmacological treatments, which bolsters the demand for steroid therapies. Initiatives aimed at educating pet owners, active online communities, and enhanced communication from veterinarians have facilitated better recognition of symptoms and the associated benefits of steroid treatments. As diagnostic methods advance and communication improves, pet owners tend to adhere more closely to prescribed steroid regimens, ultimately leading to greater market penetration and wider acceptance of steroid products within the realm of companion animal healthcare.

Restraints in the Global Steroids For Pets Market

The Global Steroids for Pets market faces significant challenges due to stringent regulatory frameworks and heightened safety concerns surrounding steroid use in animals. These factors add complexity and elevate costs associated with product approval and post-market monitoring, which can hinder the timely introduction of new formulations. Additionally, apprehensions regarding potential adverse effects, risks linked to prolonged usage, and the possibility of misuse necessitate more rigorous labeling and oversight. Consequently, both veterinarians and pet owners tend to be more cautious in prescribing and administering steroids. This cautious approach can limit the routine use of such products, restrict the variety available in the market, and deter manufacturers from attempting to enter this segment, even in the presence of obvious clinical demand.

Market Trends of the Global Steroids For Pets Market

The Global Steroids for Pets market is witnessing a significant shift as pet owners increasingly treat their animals as integral family members, fueling a demand for personalized treatment options. This trend emphasizes the importance of individualized care, with owners seeking transparent communication regarding the benefits and administration of steroid therapies. There is a growing preference for formulations that promote wellness and minimize stress while enhancing the quality of life for pets. Consequently, manufacturers are responding by developing user-friendly dosing solutions, comprehensive educational resources, and adherence programs, positioning themselves to meet owner expectations and reinforce brand loyalty, ultimately fostering a premium market presence.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Steroids for Pets Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Anabolic Steroids
  • Injectable Anabolics
  • Oral Anabolics
• Corticosteroids
  • Topical Corticosteroids
  • Injectable Corticosteroids

Global Steroids for Pets Market Size by Formulation Type & CAGR (2026-2033)

• Market Overview
• Tablets
• Liquid Solutions
• Powdered Form

Global Steroids for Pets Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Dogs
• Cats
• Others

Global Steroids for Pets Market Size by End User & CAGR (2026-2033)

• Market Overview
• Veterinary Clinics
• Pet Owners
• Pet Pharmacies

Global Steroids for Pets Market Size & CAGR (2026-2033)

• North America (Product Type, Formulation Type, Animal Type, End User)
  • US
  • Canada
• Europe (Product Type, Formulation Type, Animal Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Formulation Type, Animal Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Formulation Type, Animal Type, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Formulation Type, Animal Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VytoMed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PetMed Express
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VetEmergencies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PetSage
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arecibo Animal Hospital
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PetTech Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VetBiologics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Animal Health International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Veterinary Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScanVet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Royal Canin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PetIQ
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nutramax Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations